A role for p53 in the frequency and mechanism of mutation

被引:67
作者
Morris, SM [1 ]
机构
[1] Natl Ctr Toxicol Res, Div Genet & Reprod Toxicol, Jefferson, AR 72079 USA
关键词
p53; mutant p53; loss-of-function; knockout;
D O I
10.1016/S1383-5742(01)00075-8
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The tumor suppressor protein. p53, is often referred to as the guardian of the genome. when p53 function is impaired, its ability to preserve genomic integrity is compromised. This may result in an increase in mutation on both a molecular and chromosomal level and contribute to the progression to a malignant phenotype. In order to study the effect of p53 function on the acquisition of mutation, in vitro and in vivo models have been developed in which both the frequency and mechanism of mutation can be analyzed. In human lymphoblastoid cells in which p53 function was impaired, both the spontaneous and induced mutant frequency increased at the autosomal thymidine kinase (TK) locus. The mutant frequency increased to a greater extent in cell lines in which p53 harbored a point mutation than in those lines in which a "null" mutation had been introduced by molecular targeting or by viral degradation indicating a possible "gain-of-function" associated with the mutant protein. Further, molecular analysis revealed that the loss of p53 function was associated with a greater tendency towards loss-of-heterozygosity (LOH) within the TK gene that was due to non-homologous recombination than that found in wild-type cells. Most data obtained from the in vivo models uses the LacI reporter gene that does not efficiently detect mutation that results in LOH. However, studies that have examined the effect of p53 status on mutation in the adenine phosphoribosyl transferase (APRT) gene in transgenic mice also suggest that loss of p53 function results in an increase in mutation resulting from non-homologous recombination. The results of these studies provide clear and convincing evidence that p53 plays a role in modulating the mutant frequency and the mechanism of mutation. In addition, the types of mutation that occur within the p53 gene are also of importance in determining the mutant frequency and the pathways leading to mutation, Published by Elsevier Science B.V.
引用
收藏
页码:45 / 62
页数:18
相关论文
共 154 条
  • [1] Agami R, 1999, NATURE, V399, P809
  • [2] Albor A, 1998, CANCER RES, V58, P2091
  • [3] Maintenance of genomic integrity by p53:: complementary roles for activated and non-activated p53
    Albrechtsen, N
    Dornreiter, I
    Grosse, F
    Kim, E
    Wiesmüller, L
    Deppert, W
    [J]. ONCOGENE, 1999, 18 (53) : 7706 - 7717
  • [4] Roles for p53 in growth arrest and apoptosis: putting on the brakes after genotoxic stress
    Amundson, SA
    Myers, TG
    Fornace, AJ
    [J]. ONCOGENE, 1998, 17 (25) : 3287 - 3299
  • [5] DIFFERENT CYTOTOXIC AND MUTAGENIC RESPONSES INDUCED BY X-RAYS IN 2 HUMAN LYMPHOBLASTOID CELL-LINES DERIVED FROM A SINGLE DONOR
    AMUNDSON, SA
    XIA, F
    WOLFSON, K
    LIBER, HL
    [J]. MUTATION RESEARCH, 1993, 286 (02): : 233 - 241
  • [6] Post-translational modifications and activation of p53 by genotoxic stresses
    Appella, E
    Anderson, CW
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 2001, 268 (10): : 2764 - 2772
  • [7] Regulation of p53 stability
    Ashcroft, M
    Vousden, KH
    [J]. ONCOGENE, 1999, 18 (53) : 7637 - 7643
  • [8] Involvement of p53 in X-ray induced intrachromosomal recombination in mice
    Aubrecht, J
    Secretan, MB
    Bishop, AJR
    Schiestl, RH
    [J]. CARCINOGENESIS, 1999, 20 (12) : 2229 - 2236
  • [9] P53 BINDS SINGLE-STRANDED-DNA ENDS AND CATALYZES DNA RENATURATION AND STRAND TRANSFER
    BAKALKIN, G
    YAKOVLEVA, T
    SELIVANOVA, G
    MAGNUSSON, KP
    SZEKELY, L
    KISELEVA, E
    KLEIN, G
    TERENIUS, L
    WIMAN, KG
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (01) : 413 - 417
  • [10] Increase of spontaneous intrachromosomal homologous recombination in mammalian cells expressing a mutant p53 protein
    Bertrand, P
    Rouillard, D
    Boulet, A
    Levalois, C
    Soussi, T
    Lopez, BS
    [J]. ONCOGENE, 1997, 14 (09) : 1117 - 1122